Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing desvenlafaxine succinate sustained release to escitalopram in postmenopausal women with depression has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Depressive Disorder Major
• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release (Desvenlafaxine)
• Escitalopram (escitalopram)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression, Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-06-29